Not finding it? Sign in to also search OpenAlex live.
-
Comprehensive In Vitro Profiling Demonstrates Successful Immune Evasion of Bioengineered Immune‐Shielded Heart Valves2026 Advanced Healthcare Materials article Medicine Tissue Engineering and Regenerative Medicine Open access
Abraham van Wijk, Leanne Van den Berg, Isa B. M. Velraeds, Valentina Osorio Zuluaga, Emma T. M. Peereboom, Martijn J. W. E. Rabelink, +6 more
0citations -
Activated CD4+ T Cells and Highly Differentiated Alloreactive CD4+ T Cells Distinguish Operationally Tolerant Liver Transplantation Recipients2021 Liver Transplantation article Immunology and Microbiology T-cell and B-cell Immunology Open access
Aafke A. Duizendstra, Robert Jacobus de Knegt, Shanta Mancham, Mariska Klepper, Dave L. Roelen, Simone H. Brand‐Schaaf, +8 more
12citations -
HOPE treatment prior to organ transplant alters key immune modulators in patients receiving liver transplantation2025 Zeitschrift für Gastroenterologie conference-paper Medicine Organ Transplantation Techniques and Outcomes
Johanna Reißing, Maike R. Pollmanns, Johan Hohenschwert, Dominik Krautgartner, Felix Oldhafer, Ulf P. Neumann, +4 more
0citations -
International consensus on post-transplantation diabetes mellitus2023 Nephrology Dialysis Transplantation article Medicine Renal Transplantation Outcomes and Treatments Open access
Adnan Sharif, Harini A. Chakkera, Aiko P. J. de Vries, Kathrin Eller, Martina Guthoff, Maria C. Haller, +12 more
113citations -
A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT
Frederik Haupenthal, Jette Rahn, Fabrizio Maggi, Fanny Gelas, Philippe Bourgeois, Christian Hugo, +26 more
61citations -
10-day decitabine versus conventional chemotherapy (“3+7”) followed by allografting in AML patients ≥ 60 years: Long-term follow-up results of the randomized phase III trial AML21 of the EORTC leukemia group, GIMEMA and german MDS Study group
Michael Lübbert, Pierre W. Wijermans, Michal Kiciński, Sylvain Chantepie, Walter J. F. M. van der Velden, Richard Noppeney, +29 more
2citations
18 results